Search

Your search keyword '"McCluggage, W Glenn"' showing total 168 results

Search Constraints

Start Over You searched for: Author "McCluggage, W Glenn" Remove constraint Author: "McCluggage, W Glenn" Topic ovarian neoplasms Remove constraint Topic: ovarian neoplasms
168 results on '"McCluggage, W Glenn"'

Search Results

1. Reply to Letter by Cyrta et al, Entitled "Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)".

2. SATB2 Cytoplasmic Expression is Characteristic of a Subset of Ovarian Stromal Cells and Sex Cord Stromal Tumors.

3. Editorial: Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma.

4. The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas?

5. Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.

6. Teratoma-associated and so-called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features.

7. Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer.

8. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.

9. Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.

10. Clinicopathologic Analysis and Molecular Profiling of Ovarian Steroid Cell Tumors.

11. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.

12. Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature Review.

13. Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance.

14. Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis.

15. Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.

17. Adult Granulosa Cell Tumour With Heterologous Adipocytic Differentiation: Report of a Unique Case.

18. DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.

19. The diverse morphology and immunophenotype of ovarian endometrioid carcinomas.

20. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.

21. A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.

22. Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.

23. Microscopic Sertoliform Sex Cord Proliferations: A Rare Incidental Finding Associated With Endometriosis and Ovarian Epithelial Neoplasia.

24. Ovarian Signet-ring Stromal Tumor: A Morphologic, Immunohistochemical, and Molecular Study of 7 Cases With Discussion of the Differential Diagnosis.

25. Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification.

26. The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance.

27. Clinical utility of pathology data: endometrial and tubo-ovarian carcinomas.

28. Mesonephric-like Adenocarcinoma of the Female Genital Tract: From Morphologic Observations to a Well-characterized Carcinoma With Aggressive Clinical Behavior.

29. An Unusual Enteric Yolk Sac Tumor: First Report of an Ovarian Germ Cell Tumor Associated With a Germline Pathogenic Variant in DICER1.

30. Ovarian Low-grade Basaloid Carcinoma Arising in Brenner Tumor: A New Variant of Malignant Brenner Tumor.

31. Ovarian microcystic stromal tumour: from morphological observations to syndromic associations.

32. Bronchus-like Structures in Ovarian Teratomas: Report of a Series of a Previously Unreported Phenomenon With Potential For Misdiagnosis.

33. WT1 Positive Ovarian Endometrioid Tumors: Observations From Consult Cases and Strategies for Distinguishing From Serous Neoplasms.

34. Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study.

35. Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum.

36. Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series.

37. Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach.

38. Tubo-ovarian high-grade serous carcinomas commonly express CA19.9.

39. Pelvic and Ovarian Recurrence of Small HPV-associated Cervical Adenocarcinoma With Transformation to Neuroendocrine Carcinoma.

40. Progress in the pathological arena of gynecological cancers.

41. A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 Cases.

42. SWI/SNF-deficient malignancies of the female genital tract.

43. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.

44. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.

45. Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series.

46. Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.

47. Late Development of Metastatic Ovarian Mucinous Adenocarcinoma From Primary Gallblader Adenocarcinoma and High-grade Dysplasia.

48. KRAS-mutated Uterine Endometrioid Carcinoma With Extensive Surface Changes Resulting in Striking Morphologic Mimicry of an Ovarian Serous Borderline Tumor.

49. Primary Ovarian High-grade Neuroendocrine Carcinoma With Merkel Cell-like Immunophenotype Arising in a Teratoma.

50. Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.

Catalog

Books, media, physical & digital resources